Summary
DNA intercalators are one of the most commonly used chemotherapeutic agents. Novel intercalating compounds of pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline series having a butylamino or piperazino group at fourth position (BPSQ and PPSQ, respectively) are studied. Our results showed that BPSQ induced cytotoxicity whereas PPSQ was cytostatic. The cytotoxicity induced by BPSQ was concentration- and time-dependent. Cell cycle analysis and tritiated thymidine assay revealed that BPSQ affects the cell cycle progression by arresting at S phase. The absence of p-histone H3 and reduction in the levels of PCNA in the cells treated with BPSQ further confirmed the cell cycle arrest. Further, annexin V staining, DNA fragmentation, nuclear condensation and changes in the expression levels of BCL2/BAD confirmed the activation of apoptosis. Activation of caspase 8 and lack of cleavage of caspase 9, caspase 3 and PARP suggest the possibility of BPSQ triggering extrinsic pathway for induction of apoptosis, which is discussed. Hence, we have identified a novel compound which would have clinical relevance in cancer chemotherapeutics.
Similar content being viewed by others
References
Kirsch IR (1993) The causes and consequences of chromosomal translocations. CRC, Boca Raton
Nambiar M, Kari V, Raghavan SC (2008) Chromosomal translocations in cancer. Biochim Biophys Acta 1786:139–152
Raghavan SC, Lieber MR (2007) DNA structure and human diseases. Front Biosci 12:4402–4408. doi:10.2741/2397
Raghavan SC et al (2004) A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428(6978):88–93. doi:10.1038/nature02355
Raghavan SC, Kirsch IR, Lieber MR (2001) Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J Biol Chem 276(31):29126–29133. doi:10.1074/jbc.M103797200
Rowley JD (2001) Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 1:245–250. doi:10.1038/35106108
Dervan PB (2001) Molecular recognition of DNA by small molecules. Bioorg Med Chem 9:2215–2235. doi:10.1016/S0968-0896(01)00262-0
Thurston DE (1999) Nucleic acid targeting: therapeutic strategies for the 21st century. Br J Cancer 80:65–85
Hurley LH (2002) DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2:188–200. doi:10.1038/nrc749
Viglasky V, Danko P (2007) Intercalators: contra cruciform extrusion in DNA. Anal Biochem 360(1):7–13. doi:10.1016/j.ab.2006.10.023
Berman HM, Young PR (1981) The interaction of intercalating drugs with nucleic acids. Annu Rev Biophys Bioeng 10:87–114. doi:10.1146/annurev.bb.10.060181.000511
Wilson WD, Jones RL (1981) Intercalating drugs: DNA binding and molecular pharmacology. Adv Pharmacol Chemother 18:177–222. doi:10.1016/S1054-3589(08)60255-0
Martinez R, Chacon-Garcia L (2005) The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work. Curr Med Chem 12(2):127–151
Baguley BC (1991) DNA intercalating anti-tumor agents. Anticancer Drugs 6:1–35
Catoen-Chackal S et al (2004) DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents. J Med Chem 47(14):3665–3673. doi:10.1021/jm0400193
Tilak Raj T, Ambeker SY (1988) Synthesis of pyrimido[4′,5′:4,5]thieno(2,3-b)quinoline-4(3H)-ones. J Chem Res 50:537–551
Nandeeshaiah SK, Ambekar SY (1998) Synthesis, Dimroth rearrangment and blood platelet disaggregation property of pyrimido[4′,5′:4,5]selenolo(2,3-b)quinolines: a new class of condensed quinoline. Indian J Chem 37:995–1000
Nandeeshaiah SK, Ambeker SY (1994) Synthesis of 2-aryl-1,2,3,4-tetrahydropyrido [2′,3′:4,5] thieno[2,3-b]quinolin-4-ones. Indian J Chem 33:375–379
Via LD et al (2001) Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazo quinazoline derivatives as potential anti-tumor agents. Farmaco 56:159–167. doi:10.1016/S0014-827X(01)01079-5
Gopal M, Shahabuddin MS, Inamdar SR (2002) Interaction between 8-methoxypyrimido [4′,5′:4,5]thieno(2,3-b)quinoline-4(3H)-one antitumour drug and deoxyribo nucleic acid. Proc Indiana Acad Sci 114:687–696. doi:10.1007/BF02708861
Gopal M, Shenoy S, Doddamani LS (2003) Antitumour activity of 4-amino and 8-methly-4-(3-diethyl aminopropylamino)pyrimido[4′,5′:4,5]thieno(2,3-b)quinoline. J Photochem Photobiol B 72:69–78. doi:10.1016/j.jphotobiol.2003.09.003
Gopal M, Veeranna S, Doddamani LS (2004) Intercalation binding of 4-butylamino pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline to DNA: relationship with invitro cytotoxicity. Spectrosc Lett 37(4):347–366. doi:10.1081/SL-120039469
Shahabuddin MS, Gopal M, Raghavan SC (2007) Intercalating and antitumour activity of 4-oxopyrimido[4′,5′:4,5]thieno(2,3-b)quinoline-4(3H)-one. J Cancer Mol 3(5):139–146
Shahabuddin MS, Gopal M, Raghavan SC (2008) Intercalating, cytotoxic, antitumour activity of 8-Chloro and 4-Morpholinopyrimido [4′,5′:4,5]thieno(2,3-b)quinolines. J Photochem Photobiol 94:13–19
Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241. doi:10.1016/S0140-6736(00)02490-9
El-Bayoumy K, Sinha R (2004) Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551(1–2):181–197. doi:10.1016/j.mrfmmm.2004.02.023
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63. doi:10.1016/0022-1759(83)90303-4
Anto RJ, Maliekal TT, Karunagaran D (2000) L-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosis. J Biol Chem 275(21):15601–15604. doi:10.1074/jbc.C000105200
Vermes I et al (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39–51. doi:10.1016/0022-1759(95)00072-I
Mukhopadhyay P et al (2007) Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protocols 2(9):2295–2301. doi:10.1038/nprot.2007.327
Singh NP et al (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175(1):184–191. doi:10.1016/0014-4827(88)90265-0
Takefumi K et al (2003) Ritterazine B, a new cytotoxic narural compound, induces apoptosis in cancer cells. Cancer Chemother Pharmacol 51:202–208
Kaufmann SH et al (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53(17):3976–3985
Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18(53):7644–7655. doi:10.1038/sj.onc.1203015
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307–310. doi:10.1038/35042675
Ogawara Y et al (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277(24):21843–21850. doi:10.1074/jbc.M109745200
Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumour effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–741. doi:10.1016/S0006-2952(98)00307-4
Nelson SM, Ferguson LR, Denny WA (2004) DNA and the chromosome—varied targets for chemotherapy. Cell Chromosome 3(1):2. doi:10.1186/1475-9268-3-2
Ahsan H et al (2007) Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett 249:198–208. doi:10.1016/j.canlet.2006.08.018
Pastwa E et al (1998) Cytotoxic and DNA-damaging properties of N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues. Biochem Pharmacol 56:351–359. doi:10.1016/S0006-2952(98)00030-6
Auclair C et al (1988) Relationship between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCD); comparison with related antitumour agents. Anticancer Drug Des 3:133–139
Baez A et al (1983) Interaction between a 3-Nitrobenzo thiazolo (3,2-a)quinolinium antitumour drug and deoxyribonucleic acid. Biochem Pharmacol 32:2089–2094. doi:10.1016/0006-2952(83)90431-8
Lin J et al (2003) Effects of astragali radix on the growth of different cancer cell lines. World J Gastroenterol 9(4):670–673
Cattaneo-Pangrazzi RM et al (2000) Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. J Cancer Res Clin Oncol 126(5):247–256. doi:10.1007/s004320050339
Leonce S et al (2001) Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. Mol Pharmacol 60(6):1383–1391
Chen HY et al (2004) Peplomycin induces G1 phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2 phase arrest. Acta Pharmacol Sin 25(12):1698–1704
Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20(4):214–220. doi:10.1016/j.tig.2004.02.007
Reed JC (2008) Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111(7):3322–3330. doi:10.1182/blood-2007-09-078162
Kaina B (2003) DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol 66(8):1547–1554. doi:10.1016/S0006-2952(03)00510-0
Kelekar A, Thompson CB (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol 8(8):324–330. doi:10.1016/S0962-8924(98)01321-X
Seki T et al (2001) Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene. Anticancer Res 21(3B):1919–1924
Boldt S, Weidle UH, Kolch W (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23(11):1831–1838. doi:10.1093/carcin/23.11.1831
Marshall C (1999) How do small GTPase signal transduction pathways regulate cell cycle entry? Curr Opin Cell Biol 11(6):732–736. doi:10.1016/S0955-0674(99)00044-7
van den Brink MR et al (1999) The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 274(16):11178–11185. doi:10.1074/jbc.274.16.11178
Basu S et al (1998) BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem 273(46):30419–30426. doi:10.1074/jbc.273.46.30419
Bacus SS et al (2001) Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20(2):147–155. doi:10.1038/sj.onc.1204062
Acknowledgements
We thank Prof. Ambeker SY and members of the SCR laboratory for discussions and help. This work was supported by Lady Tata Memorial Trust international award for leukemia research, London; grants from DBT, India (BT/PRS129/GBD/27/7/2006), and IISc start up grant for SCR. We also thank Dr. Raghavan Varadarajan for financial assistance. SMS is supported by DBT postdoctoral fellowship from DBT, India. MN is supported by senior research fellowship from CSIR, India.
Conflict of interest statement
Authors disclose that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. S. Shahabuddin and Mridula Nambiar contributed equally to the work.
Rights and permissions
About this article
Cite this article
Shahabuddin, M.S., Nambiar, M., Choudhary, B. et al. A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells. Invest New Drugs 28, 35–48 (2010). https://doi.org/10.1007/s10637-008-9212-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-008-9212-6